{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:40:03Z","timestamp":1790203203022,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National University of La Plata (UNLP)","award":["Incentivos X-597"],"award-info":[{"award-number":["Incentivos X-597"]}]},{"DOI":"10.13039\/501100002923","name":"National Council for Scientific and Technical Research (CONICET)","doi-asserted-by":"crossref","award":["PIP 11220090100603"],"award-info":[{"award-number":["PIP 11220090100603"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002923","name":"National Council for Scientific and Technical Research (CONICET)","doi-asserted-by":"crossref","award":["Res 3646\/14"],"award-info":[{"award-number":["Res 3646\/14"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Agency for Scientific and Technological Promotion (ANPCyT)","award":["PICTs 2010-1774"],"award-info":[{"award-number":["PICTs 2010-1774"]}]},{"name":"National Agency for Scientific and Technological Promotion (ANPCyT)","award":["2013-3175"],"award-info":[{"award-number":["2013-3175"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.eplepsyres.2016.10.012","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T04:30:23Z","timestamp":1477542623000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["New model of pharmacoresistant seizures induced by 3-mercaptopropionic acid in mice"],"prefix":"10.1016","volume":"129","author":[{"given":"Andrea","family":"Enrique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bruno Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eplepsyres.2016.10.012_bib0005","first-page":"145","article-title":"Seizure attainment and mortality of mice in kainite-induced status epilepticus","volume":"5","author":"Ahmad","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.eplepsyres.2016.10.012_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.0013-9580.2004.57703.x","article-title":"Expression and cellular distribution of multidrug resistance-related protein in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"45","author":"Aronica","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11064-008-9828-0","article-title":"The NMDAR Subunit NR2B Expression is modified in Hippocampus after Repetitive Seizures","volume":"34","author":"Auzmendi","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.10.012_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2011.12.014","article-title":"Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy","volume":"234","author":"Bankstahl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0030","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"12","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.eplepsyres.2014.05.008","article-title":"Antiepileptic efficacy of lamotrigine in Phenobarbital resistant and responsive epileptic rats: a pilot","volume":"108","author":"Brandt","year":"2014","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.10.012_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0091-3057(02)01040-7","article-title":"Comparative anticonvulsant activity of some 2,3-benzodiazepine derivates in rodents","volume":"74","author":"De Sarro","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0197-0186(99)00116-3","article-title":"Effects of an adenosine analogue administration on the striatal NMDA receptors in an experimental model of epilepsy","volume":"36","author":"Giraldez","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1023\/A:1020964721242","article-title":"Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration","volume":"24","author":"Giraldez","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0197-0186(89)90059-4","article-title":"Increase of 5-nucleotidase activity in some brain subcellular fractions after the administration of the convulsant 3-mercaptopropionic acid","volume":"14","author":"Girardi","year":"1989","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/B:NERE.0000013739.15160.a8","article-title":"Astrocytic response in hippocampus and cerebral cortex in an experimental epilepsy model in rat","volume":"29","author":"Girardi","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10571-013-9947-2","article-title":"3-mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine","volume":"33","author":"Gori","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2006.11.075","article-title":"Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model","volume":"413","author":"Hocht","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2009.01.079","article-title":"Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid","volume":"453","author":"Hocht","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0090","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1476-5381.2009.00634.x","article-title":"Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats","volume":"159","author":"Jing","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/NDT.S50371","article-title":"Animal models of epilepsy: use and limitations","volume":"10","author":"Kandratavicius","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.10.012_bib0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1167.2008.01916.x","article-title":"Complex time-dependent alterations in the brain expression of different drug efflux transporter genes alter status epilepticus","volume":"50","author":"Kuteykin-Teplyakov","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"L\u00f6scher","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.10.012_bib0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(93)90058-F","article-title":"Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy","volume":"15","author":"L\u00f6scher","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0125","series-title":"Models of Seizures and Epilepsy","article-title":"Animal models of drug-refractory epilepsy","author":"L\u00f6scher","year":"2006"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical Review of current animal models of seizure and epilepsy used in discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"issue":"S28","key":"10.1016\/j.eplepsyres.2016.10.012_bib0135","article-title":"High expression of multidrug resistance gene (MDR-1) and persistent low levels of phenytoin (PHT) on a patient with refractory epilepsy due to tuberous sclerosis (TS)","volume":"150","author":"Lazarowski","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.eplepsyres.2016.10.012_bib0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:CEMN.0000012726.43842.d2","article-title":"Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model","volume":"24","author":"Lazarowski","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.eplepsyres.2016.10.012_bib0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy","volume":"48","author":"Lazarowski","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.eplepsyres.2014.02.013","article-title":"Low potency and limited efficacy of antiepileptic drugs in the mouse 6Hz corneal kindling model","volume":"108","author":"Leclercq","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0155","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna Tort\u00f3s","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1157.1972.tb04401.x","article-title":"A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol","volume":"13","author":"Mason","year":"1972","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2885.2010.01170.x","article-title":"Oral bioavailability of P-glycoprotein substrate drugs do not differ between ABCB1- 1D and ABCB1 wild type dogs","volume":"33","author":"Mealey","year":"2010","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.10.012_bib0170","first-page":"140","article-title":"Amino acid neurotransmitters and new approaches to anticonvulsant drug action","volume":"25","author":"Meldrum","year":"1984","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2016.10.012_bib0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tips.2010.03.003","article-title":"Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier","volume":"31","author":"Miller","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.10.012_bib0180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cpt.64","article-title":"Regulation of ABC transporters at the blood-brain barrier","volume":"97","author":"Miller","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbrc.2009.09.035","article-title":"Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling","volume":"390","author":"Ohno","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0190","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eplepsyres.2010.01.011","article-title":"Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model","volume":"89","author":"Ohno","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2125.2001.01359.x","article-title":"Carbamazepine is not a substrate for P-glycoprotein","volume":"51","author":"Owen","year":"2001","journal-title":"Blackwell Sci. Ltd. Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.eplepsyres.2016.10.012_bib0200","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/pgs.10.126","article-title":"Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches","volume":"11","author":"Potschka","year":"2010","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.10.012_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1684\/epd.2012.0532","article-title":"Animal models of drug-resistant epilepsy","volume":"14","author":"Potschka","year":"2012","journal-title":"Epileptic Disord."},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.10.012_bib0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0215","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1523\/JNEUROSCI.22-14-05833.2002","article-title":"Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance","volume":"22","author":"Rizzi","year":"2002","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.10.012_bib0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/epi.12182","article-title":"The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1528-1157.2002.33101.x","article-title":"Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats","volume":"43","author":"Seegers","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/0470846356.ch12","article-title":"Drug resistance in epilepsy: human epilepsy","volume":"243","author":"Sisodiya","year":"2002","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1471-4159.2009.06539.x","article-title":"Stress and GABAa receptors","volume":"112","author":"Skilbeck","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1969.tb46402.x","article-title":"Convulsant activity of homocysteine and other short-chain mercaptoacids: protection therefrom","volume":"166","author":"Sprince","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0245","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1734-1140(12)70900-3","article-title":"The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs","volume":"64","author":"Stepien","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1995.tb01657.x","article-title":"MDR1 Gene expression in brain of patient with medically intractable epilepsy","volume":"36","author":"Tishler","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.expneurol.2009.05.005","article-title":"Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex","volume":"219","author":"Vil\u00e1gi","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0260","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.eplepsyres.2016.10.012_bib0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.44.s7.10.x","article-title":"Preclinical development of antiepileptic drugs: past, present, and future directions","volume":"44","author":"White","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.10.012_bib0270","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.addr.2011.12.003","article-title":"The transport of antiepileptic drugs by P-glycoprotein","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116302509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116302509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:35:38Z","timestamp":1760276138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116302509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"alternative-id":["S0920121116302509"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.10.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New model of pharmacoresistant seizures induced by 3-mercaptopropionic acid in mice","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}